Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Shooter 

Protagonist Therapeutics Inc diskutieren

Protagonist Therapeutics Inc

WKN: A2AP32 / Symbol: PTGX / Name: Protagonist / Aktie / Micro Cap /

118,00 €
-5,65 %

27 0
27
0

Protagonist Therapeutics (PTGX) was upgraded by Wolfe Research to "strong-buy".
Ratings data for PTGX provided by MarketBeat

Wolfe Research 
0
Melden Teilen
22.05.26 Buy 40,48 %

Protagonist Therapeutics (PTGX) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for PTGX provided by MarketBeat

TD Cowen 
0
Melden Teilen
01.07.26 Buy 4,42 %

Protagonist Therapeutics (PTGX) had its "outperform" rating reaffirmed by Citigroup Inc..
Ratings data for PTGX provided by MarketBeat

Citigroup Inc. 
0
Melden Teilen
17.07.26 Buy -4,84 %
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

Roth_Mkm in Calix Inc. diskutieren
Calix (CALX) had its "buy" rating reaffirmed by Roth Capi...
21:15
JPMorgan_Chase___Co_ in Bloom Energy Corp diskutieren
Bloom Energy (BE) had its price target raised by JPMorgan...
21:00
UBS_Group_AG in Varonis Systems Inc. diskutieren
Varonis Systems (VRNS) had its price target raised by UBS...
20:45
Piper_Sandler in Innovative Industrial Properties Inc diskutieren
Innovative Industrial Properties (IIPR) had its price tar...
20:00
Northland_Securities in Calix Inc. diskutieren
Calix (CALX) was upgraded by Northland Securities from "m...
20:00
Truist_Financial_Co_ in Varonis Systems Inc. diskutieren
Varonis Systems (VRNS) had its price target raised by Tru...
19:00
JPMorgan_Chase___Co_ in Park Hotels & Resorts Inc diskutieren
Park Hotels & Resorts (PK) had its price target raise...
17:45
Royal_Bank_of_Canada in Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics (KPTI) had its "outperform" ratin...
16:15
Mehr anzeigen